News from volitionrx limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 06, 2021, 08:25 ET VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it has been awarded additional non-dilutive funding totaling approximately $4...


Feb 07, 2020, 17:30 ET VolitionRx Announces Filing of Registration Statements

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has filed registration statements on Form S-3 and Form S-8,...


Nov 07, 2018, 16:05 ET VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the quarter ended September 30,...


Oct 31, 2018, 16:30 ET VolitionRx Limited Schedules Third Quarter 2018 Earnings Conference Call and Business Update

VolitionRx Limited (NYSE American: VNRX) today announced it will host a conference call on Thursday, November 8 at 8:30 a.m. Eastern time to discuss...


Oct 04, 2018, 09:00 ET VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced very encouraging preliminary results from a proof of concept study using its Nu....


Jul 02, 2018, 08:30 ET Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded additional non-dilutive funding of approximately...


Feb 26, 2018, 04:05 ET VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced interim results from its first asymptomatic colorectal cancer (CRC) frontline...


Nov 02, 2017, 08:30 ET VolitionRx Limited Schedules Third Quarter 2017 Earnings Conference Call and Business Update

VolitionRx Limited (NYSE American: VNRX) today announced it will host a conference call on Friday, November 10 at 8:30 a.m. Eastern time to discuss...


Sep 21, 2017, 16:30 ET VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded a loan and a non-repayable grant totaling $1.5 million ...


Aug 03, 2017, 16:30 ET VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update

VolitionRx Limited (NYSE AMERICAN: VNRX) today announced it will host a conference call on Thursday, August 10, 2017 at 8:30 am Eastern time to...


Jul 19, 2017, 16:30 ET VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute

VolitionRx Limited (Volition; NYSE MKT: VNRX), announced it will host a conference call tomorrow, July 20 at 8:30 AM U.S. Eastern Time to discuss its ...


May 26, 2017, 06:30 ET VolitionRx Limited to Present at Multiple Investor Conferences in June

VolitionRx Limited (NYSE MKT: VNRX) today announced it is scheduled to present at multiple investor conferences in June. Dr. Scott Powell, Executive...


May 11, 2017, 06:30 ET VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update

VolitionRx Limited (NYSE MKT: VNRX) ("Volition") today announced financial results for the quarter ended March 31, 2017 and provided a business...


Apr 21, 2017, 08:26 ET Volition opens a new Research and Development facility in Belgium with a state of the art, purpose-built laboratory

VolitionRx Limited (NYSE MKT: VNRX) opened its new research and development facility this week. A video showcasing the new facility and opening event ...


Mar 28, 2017, 16:01 ET Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

Volition America, Inc., a wholly-owned U.S. subsidiary of VolitionRx Limited (NYSE MKT: VNRX), today announced the engagement of Deborah Vollmer...


Mar 20, 2017, 06:30 ET VolitionRx Limited Announces the Formation of Volition America, Inc.

VolitionRx Limited (NYSE MKT: VNRX) today announced the creation of a wholly-owned U.S. subsidiary, Volition America, Inc., which will be based in...


Mar 14, 2017, 13:56 ET VolitionRx Limited Celebrates CE Mark Announcement By Ringing Closing Bell at the New York Stock Exchange

VolitionRx Limited (NYSE MKT: VNRX) celebrated the company's recent announcement of a CE mark for its Nu.QTM Colorectal Cancer Screening Triage Test...


Mar 13, 2017, 06:30 ET VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time

VolitionRx Limited (NYSE MKT: VNRX) announced today that members of its senior management team and Board of Directors, including Chief Executive...


Feb 24, 2015, 08:00 ET VolitionRx Acquires Direct Ownership of Nucleosomics® Technology Patent

VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and ...


Feb 06, 2015, 08:00 ET VolitionRx Limited Prices Public Offering of Common Stock

VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and ...


Nov 24, 2014, 08:00 ET VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced...


Nov 05, 2014, 08:00 ET VolitionRx to Present at the SeeThruEquity Conference

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and...


Oct 31, 2014, 08:00 ET VolitionRx Initiates Sponsorship of Two-time Cancer Survivor to Drive Awareness for the Importance of Early Cancer Detection

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests, today announced that it has initiated...


Oct 02, 2014, 08:00 ET VolitionRx Announces Prostate Cancer Collaboration with the University of Texas MD Anderson Cancer Center

olitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


Sep 05, 2014, 06:30 ET VolitionRx to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types, today ...